100 related articles for article (PubMed ID: 16815870)
1. Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice.
Margalit M; Shalev Z; Pappo O; Sklair-Levy M; Alper R; Gomori M; Engelhardt D; Rabbani E; Ilan Y
J Pharmacol Exp Ther; 2006 Oct; 319(1):105-10. PubMed ID: 16815870
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping.
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
J Pathol; 2006 May; 209(1):121-8. PubMed ID: 16482497
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A
Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.
Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM
Hepatology; 2004 Aug; 40(2):434-41. PubMed ID: 15368448
[TBL] [Abstract][Full Text] [Related]
6. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
Li Z; Soloski MJ; Diehl AM
Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
[TBL] [Abstract][Full Text] [Related]
7. Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells.
Shabat Y; Lichtenstein Y; Zolotarov L; Ben Ya'acov A; Ilan Y
J Dig Dis; 2013 Feb; 14(2):84-92. PubMed ID: 23134214
[TBL] [Abstract][Full Text] [Related]
8. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
9. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
[TBL] [Abstract][Full Text] [Related]
10. Does leptin mediate the effect of photoperiod on immune function in mice?
Bhat GK; Hamm ML; Igietseme JU; Mann DR
Biol Reprod; 2003 Jul; 69(1):30-6. PubMed ID: 12606383
[TBL] [Abstract][Full Text] [Related]
11. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.
Margalit M; Abu Gazala S; Alper R; Elinav E; Klein A; Doviner V; Sherman Y; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G917-25. PubMed ID: 15976388
[TBL] [Abstract][Full Text] [Related]
12. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice.
Bigorgne AE; Bouchet-Delbos L; Naveau S; Dagher I; Prévot S; Durand-Gasselin I; Couderc J; Valet P; Emilie D; Perlemuter G
Gastroenterology; 2008 May; 134(5):1459-69. PubMed ID: 18471520
[TBL] [Abstract][Full Text] [Related]
13. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.
Zigmond E; Zangen SW; Pappo O; Sklair-Levy M; Lalazar G; Zolotaryova L; Raz I; Ilan Y
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E72-8. PubMed ID: 18940939
[TBL] [Abstract][Full Text] [Related]
14. Dietary docosahexaenoic acid-rich diacylglycerols ameliorate hepatic steatosis and alter hepatic gene expressions in C57BL/6J-Lep(ob/ob) mice.
Kim HJ; Lee KT; Park YB; Jeon SM; Choi MS
Mol Nutr Food Res; 2008 Aug; 52(8):965-73. PubMed ID: 18481331
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.
Safadi R; Zigmond E; Pappo O; Shalev Z; Ilan Y
Int Immunol; 2007 Aug; 19(8):1021-9. PubMed ID: 17698563
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
17. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice.
Oliveira CP; Alves VA; Lima VM; Stefano JT; Debbas V; Sá SV; Wakamatsu A; Corrêa-Giannella ML; de Mello ES; Havaki S; Tiniakos DG; Marinos E; de Oliveira MG; Giannella-Neto D; Laurindo FR; Caldwell S; Carrilho FJ
Biochem Pharmacol; 2007 Jul; 74(2):290-7. PubMed ID: 17524368
[TBL] [Abstract][Full Text] [Related]
20. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders.
Zigmond E; Preston S; Pappo O; Lalazar G; Margalit M; Shalev Z; Zolotarov L; Friedman D; Alper R; Ilan Y
Gut; 2007 Jan; 56(1):82-9. PubMed ID: 17172586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
